9 Meters Biopharma, Inc. (MNTRQ) vs ZyVersa Therapeutics, Inc. (ZVSA)

9 Meters Biopharma, Inc. and ZyVersa Therapeutics, Inc. are both Biotechnology companies. 9 Meters Biopharma, Inc. and ZyVersa Therapeutics, Inc. are of similar size ($1.0M and $970.0K). Across the 8 metrics below, 9 Meters Biopharma, Inc. leads on 4 and ZyVersa Therapeutics, Inc. on 4.

Valuation

Metric MNTRQ ZVSA Biotechnology median
P/E n/m n/m 7.88
P/S 0.07 n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.05 n/m 0.74
EV/Sales (0.54) n/m 10.73
Earnings yield (17,300.00%) (3,679.60%) (28.84%)
Free cash flow yield (13,701.96%) (511.54%) (23.03%)

Profitability

Metric MNTRQ ZVSA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (375.64%) 817.13% (57.72%)
Return on assets (190.56%) (225.42%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MNTRQ ZVSA Biotechnology median
Revenue growth (TTM) (50.82%) — 5.64%
EPS growth (last fiscal year) (12.67%) 50.71% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MNTRQ ZVSA Biotechnology median
Debt to equity (0.82) 0.00 0.00
Current ratio 0.59 0.05 4.73
Net debt to EBITDA (0.17) 0.00 0.96

Dividend

Metric MNTRQ ZVSA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric MNTRQ ZVSA Biotechnology median
Market cap 1.04m 970.00k 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack